Soldiers who survive traumatic injuries from roadside bombs in Iraq and Afghanistan face significant impairments from their wounds. A new collaboration of academic and industry researchers, including at Massachusetts General Hospital, MIT, and Dartmouth, is bringing regenerative medicine to bear on the challenge.
Formed by the US Army, the Institute of Regenerative Medicine will devote $85 million to developing products and therapies to repair blast injuries from improvised explosive devices, or IEDs, and other weapons. The approaches will include work with stem cells, growth factors, tissue and biomaterial engineering, and transplants to help the body restore or replace damaged tissues or organs, according to an announcement today from Mass. General.
Mass. General, MIT, and Dartmouth will be part of a consortium led by Rutgers University and the Cleveland Clinic. A second consortium will be headed by Wake Forest University and the University of Pittsburgh. Each will receive $42.5 million from the Army.
The Mass. General team will include clinicians and researchers from its Center for Military Biomaterials Research and from the Massachusetts Eye and Ear Infirmary.
About white coat notes
|White Coat Notes covers the latest from the health care industry, hospitals, doctors offices, labs, insurers, and the corridors of government. Chelsea Conaboy previously covered health care for The Philadelphia Inquirer. Write her at firstname.lastname@example.org. Follow her on Twitter: @cconaboy.|
Gideon Gil, Health and Science Editor
Elizabeth Comeau, Senior Health Producer